Thought Leadership

At NDA our experts stay abreast with the evolving environment and the new regulatory requirements that it gives rise to. One of the results of these activities is a stream of articles, commentaries and white papers that we publish for the benefit of our clients and followers. It captures the state of the art of our industry today.

We call it Thought Leadership.

Articles and White Papers

Service:

Scientific:

Sort by:

02-05-2020

Enhancing Pharmacovigilance

This article discusses the tremendous expansion in oncology products with great opportunities that will benefit patients.
02-08-2016

New FDA Guidance: Impact on Clinical Safety Data

As the FDA continues to tighten legislation around suspected adverse events, it becomes more important than ever to stay fully up-to-date with all the obligations and requirements.